Alzheimer's & Cognition
Conference Coverage
Aerobic exercise boosts brain power in mild cognitive impairment
Major finding: Individuals who performed aerobic exercises had a significant increase of about 2 points from baseline on a composite measure of...
News
Glucose, insulin measures unrelated to AD pathology
Major finding: There were no significant differences in mean nondementia/dementia values for fasting glucose (100/98 mg/dL), fasting insulin (9.6/...
Conference Coverage
Brain atrophy rate may predict later cognitive decline
Major finding: For patients with mild cognitive impairment, every 1% increase in the rate of whole brain atrophy during a single year was...
News
Food for thought: DASH diet slowed cognitive decline
Major finding: Closer adherence to the components of the DASH diet was significantly associated with a slower rate of cognitive decline.Data...
Conference Coverage
Florbetapir PET may rule out amyloidosis and Alzheimer’s disease
Major finding: Brain amyloid imaging with florbetapir 18F PET was consistently positive in patients with amyloid pathology, and negative in...
Conference Coverage
Two-minute Alzheimer’s test? Not so fast!
Major finding: All of 16 online tests for Alzheimer’s disease were rated as poor in all respects by two expert panels.Data source: Evaluation of...
Conference Coverage
Subjective cognitive decline may be early omen of Alzheimer’s
Conference Coverage
Slight cognition benefit found for testosterone gel after menopause
Major finding: After 6 months of daily testosterone gel, women scored 1.57 points better on the 48-point International Shopping List Task test....
Conference Coverage
In vivo tau imaging confirms patient’s Alzheimer’s diagnosis
Major finding: The results of in vivo tau tangle PET imaging with [F-18]T808 in a patient diagnosed with Alzheimer’s were later confirmed in a...
News
Cancer survivors may have lower Alzheimer’s risk
Major finding: The risk for incident Alzheimer’s disease was reduced by 51% in liver cancer survivors, 44% in survivors of pancreatic cancer, and...
Conference Coverage
IVIG falls down at GAP study’s finish line
Major finding: The use of IVIG led to no significant cognitive or functional benefits in patients with mild to moderate Alzheimer’s disease.Data...